Short answer
Advanced glycation end products, or AGEs, form when sugars react with proteins or fats and can accumulate in tissues over time. Some consumer tests or devices estimate AGE burden, often using skin autofluorescence. These tools may be interesting for research or risk discussion, but they are not a replacement for established metabolic testing such as A1C, fasting glucose, oral glucose tolerance testing, blood pressure, kidney checks, or lipid risk assessment.
Claims to separate
| Claim | Question to ask | Why it matters |
|---|---|---|
| Your AGE score predicts disease | Was the device validated for individual clinical decisions or only associated with risk in studies? | Association is not the same as diagnosis. |
| Your diet caused the score | Does the test separate dietary AGEs from blood sugar, kidney function, age, smoking, and sun exposure? | Multiple factors affect AGE biology. |
| A supplement reversed glycation | Was the change larger than device variation and tied to better outcomes? | A moving score may not equal health improvement. |
Better next steps
If glycation risk is the concern, start with validated, actionable measures: A1C, fasting glucose, diabetes risk, blood pressure, kidney function, lipid markers, smoking status, sleep, exercise, and nutrition. AGE testing should not distract from those basics.
Questions to ask
- Is this a regulated clinical test, a wellness device, or a research-style biomarker?
- What does the company prove: analytical accuracy, risk association, or improved outcomes?
- Does skin tone, skin thickness, sun exposure, age, kidney disease, or diabetes affect interpretation?
- What medical decision would change because of the result?
- If the score conflicts with A1C or symptoms, which validated test should take priority?
When the score is the wrong tool
If the question is diabetes diagnosis, kidney disease, smoking-related risk, or cardiometabolic management, validated clinical testing should lead the way. An AGE score can add context, but it should not be the test that decides whether action is needed.
Related guides: A1C test, fasting insulin and insulin resistance testing, biological age tests, and consumer oxidative stress panel claims.
FAQ
Is an AGE score the same as A1C?
No. A1C is a validated blood test for glucose exposure over time, while AGE scores are exploratory markers with a different evidence base.
Can AGE testing diagnose diabetes?
No. Diabetes diagnosis still relies on validated glucose-based testing and clinical criteria.
What affects the reading?
Skin tone, age, kidney disease, smoking, sun exposure, hydration, and device method can all affect interpretation.
Do supplements proving lower AGE scores prove benefit?
Not necessarily. A lower score does not automatically mean better outcomes unless the exact test and intervention are validated.
What should be ordered first if glycation risk matters?
Validated diabetes and cardiometabolic tests such as A1C, fasting glucose, blood pressure, lipids, and kidney checks usually come first.
When might AGE testing be useful?
It may be useful in research or as an exploratory add-on when a clinician understands the method and its limits.
What if the AGE score conflicts with A1C or symptoms?
Validated glucose-based testing and the clinical picture should take priority, because AGE scores are not established replacements for diagnosis.